{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:45:08Z","timestamp":1777934708712,"version":"3.51.4"},"reference-count":25,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Surgical Infections"],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Catheter-associated urinary tract infections (CAUTIs) account for 1 million nosocomial infections annually and 75% of all hospital-acquired UTIs. A risk factor for CAUTI is prolonged urinary catheterization (UC); therefore, transitory UC during laparoscopic appendectomy (LA), a common practice justified to avoid iatrogenic bladder injury, is believed to be safe. However, data on the incidence of post-operative UC-related complications, including CAUTI, following LA or their avoidance are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis:<\/jats:title>\n                    <jats:p>Patients who underwent UC for LA developed more post-operative UTIs than patients without UC (noUC), without effect on the incidence of bladder injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>Retrospective analysis of patients \u226521 years who underwent LA (2016\u20132023) at an academic hospital. The primary outcome was post-operative UTI in UC versus noUC patients, defined as symptoms or urinalysis findings compatible with UTI within 21 days from LA. Secondary outcomes included bladder injury, catheter-related complications, time until UTI diagnosis, and antibiotic exposure. Statistics: Mann\u2013Whitney U and Fisher exact tests; p &lt; 0.05.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among 981 LA, there were 678 UC and 303 noUC. A majority was male (56%) and young [38 years, inter-quartile range (IQR) 28\u201350]. Duration of catheterization was 102 min (IQR 85\u2013123), whereas duration of the procedure was 58 min (IQR 44\u201380). There were more catheter-related complications in the UC versus noUC group (10 [1.5%] vs. 0; p = 0.04). The incidence of UTI was 0.5%, with five cases (0.7%) after UC and zero for noUC (p = 0.34). UTIs were detected at 11 post-operative days (IQR 6\u201317) and treated with antibiotic agents for 5 days (IQR 5\u201313). Four UC patients had urinary retention (two required re-catheterization and discharge with an indwelling catheter). One UC urinary \u201cretainer\u201d developed a post-operative UTI and required hospital re-admission. There was no urinary retention in the noUC group. There were no bladder injuries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The incidence of UTI was low following LA; bladder injuries were non-existent. UC-related complications were greater among UC patients, but there was neither urinary retention and post-operative catheterization nor bladder injury in the noUC group; we suggest the omission of UC for LA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/sur.2024.196","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T12:23:32Z","timestamp":1734956612000},"page":"249-254","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Urinary Catheter Utility in Laparoscopic Appendectomy: Risk Benefit Analysis of Post-Operative Urinary Tract Complications"],"prefix":"10.1177","volume":"26","author":[{"given":"Charoo","family":"Piplani","sequence":"first","affiliation":[{"name":"Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA."},{"name":"Rutgers Acute Care Surgery Research Laboratory (RASR), New Brunswick, New Jersey, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer E.","family":"Geller","sequence":"additional","affiliation":[{"name":"Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA."},{"name":"Rutgers Acute Care Surgery Research Laboratory (RASR), New Brunswick, New Jersey, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorasicha","family":"Nithikasem","sequence":"additional","affiliation":[{"name":"Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA."},{"name":"Rutgers Acute Care Surgery Research Laboratory (RASR), New Brunswick, New Jersey, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A.","family":"Hung","sequence":"additional","affiliation":[{"name":"Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA."},{"name":"Rutgers Acute Care Surgery Research Laboratory (RASR), New Brunswick, New Jersey, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda L.","family":"Teichman","sequence":"additional","affiliation":[{"name":"Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA."},{"name":"Rutgers Acute Care Surgery Research Laboratory (RASR), New Brunswick, New Jersey, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip S.","family":"Barie","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College, Surgery and Public Health, New York, New Jersey, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayur","family":"Narayan","sequence":"additional","affiliation":[{"name":"Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA."},{"name":"Rutgers Acute Care Surgery Research Laboratory (RASR), New Brunswick, New Jersey, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2297-9956","authenticated-orcid":false,"given":"Rachel L.","family":"Choron","sequence":"additional","affiliation":[{"name":"Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA."},{"name":"Rutgers Acute Care Surgery Research Laboratory (RASR), New Brunswick, New Jersey, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"e_1_3_5_2_2","first-page":"109","article-title":"Catheter-associated urinary tract infections: Current challenges and future prospects","volume":"14","author":"Werneburg GT","year":"2022","unstructured":"Werneburg GT. Catheter-associated urinary tract infections: Current challenges and future prospects. Res Rep Urol, 2022; 14:109\u2013133; doi: 10.2147\/RRU.S273663","journal-title":"Res Rep Urol"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306801"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/003335490712200205"},{"issue":"5","key":"e_1_3_5_5_2","first-page":"CR246","article-title":"Antibiotic resistance in community-acquired urinary tract infections: Prevalence and risk factors","volume":"16","author":"Kurtaran B","year":"2010","unstructured":"Kurtaran B, , Candevir A, , Tasova Y, et al. Antibiotic resistance in community-acquired urinary tract infections: Prevalence and risk factors. Med Sci Monit, 2010 May;16(5):CR246\u2013CR251.","journal-title":"Med Sci Monit"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/657912"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1086\/673456"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2021-013839"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2013.09.002"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2019.684"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2014.00145"},{"issue":"4","key":"e_1_3_5_12_2","first-page":"277","article-title":"The antibiotic resistance crisis: Part 1: Causes and threats","volume":"40","author":"Ventola CL","year":"2015","unstructured":"Ventola CL. The antibiotic resistance crisis: Part 1: Causes and threats. P T, 2015; 40(4):277\u2013283.","journal-title":"P T"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-239361"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-19-3755-2_17"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/675718"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.2341"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)42911-9"},{"key":"e_1_3_5_18_2","unstructured":"US Food and Drug Administration. Complicated intra-abdominal infections: Developing drugs for treatment. Available from: www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/complicated-intra-abdominal-infections-developing-drugs-treatment [Last accessed: June24 2024]."},{"key":"e_1_3_5_19_2","first-page":"1","article-title":"Urinary tract infection (Catheter-associated urinary tract infection [CAUTI] and non-catheter associated urinary tract infection [UTI] Events","volume":"7","author":"National Healthcare Safety Network","year":"2024","unstructured":"National Healthcare Safety Network. Urinary tract infection (Catheter-associated urinary tract infection [CAUTI] and non-catheter associated urinary tract infection [UTI] Events. Centers for Disease Control, 2024; 7:1\u201317.","journal-title":"Centers for Disease Control"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/jan.13863"},{"key":"e_1_3_5_21_2","volume-title":"2019 Antibacterial Agents in Clinical Development: An Analysis of the Antibacterial Clinical Development Pipeline","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. 2019 Antibacterial Agents in Clinical Development: An Analysis of the Antibacterial Clinical Development Pipeline. World Health Organization; 2019."},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1108296"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000492"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11020182"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw830"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.12968\/bjcn.2020.25.11.538"}],"container-title":["Surgical Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/sur.2024.196","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/sur.2024.196","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/sur.2024.196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:31:53Z","timestamp":1777689113000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/sur.2024.196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,5,1]]}},"alternative-id":["10.1089\/sur.2024.196"],"URL":"https:\/\/doi.org\/10.1089\/sur.2024.196","relation":{},"ISSN":["1096-2964","1557-8674"],"issn-type":[{"value":"1096-2964","type":"print"},{"value":"1557-8674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}